|
|
volociximab A chimeric monoclonal antibody with potential antineoplastic activity. Volociximab binds to and inhibits the activity of alpha(5)beta(1) integrin, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
Synonyms: | | anti-alpha 5 beta 1 integrin monoclonal antibody anti-α5β1 integrin | | | Abbreviation: | | anti-α5β1 integrin MOAB | | | Code name: | | M200 | | |
|
|